Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06814938
PHASE4

A Study of a Novel Precision Medicine Approach For Obesity

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This study is being done to assess the efficacy of a saliva- based biomarker to predict response to semaglutide for the treatment of obesity.

Official title: A Novel Precision Medicine Approach For Obesity: A Randomized, Multi-Center Trial

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

135

Start Date

2025-02-21

Completion Date

2028-11

Last Updated

2026-03-02

Healthy Volunteers

No

Conditions

Interventions

DRUG

Semaglutide

2.4 mg subcutaneous weekly

DRUG

Placebo

Looks exactly like the study drug, but it contains no active ingredient administered subcutaneous weekly

Locations (2)

Mayo Clinic in Florida

Jacksonville, Florida, United States

Mayo Clinic in Rochester

Rochester, Minnesota, United States